RBR-6qbztf尚未招募未知
Randomized clinical trial of the nano-hydroxyapatite and arginine effect for the dentin sensibility prevention after bleaching home treatment
Faculdade de odontologia da Universidade Federal do Pará0 个研究点开始时间: 2015年7月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 26Y（—）
入选标准
- •60 people aged between 18 and 26 years;
- •any genders; good health; non-moking;
- •pH and salivary flow within normal limits;
- •healthy teeth and initial color A2 or darker
- •according to the Vita scale.
排除标准
- •Having received previous dental bleaching;
- •restorations on the anterior teeth; pregnant
- •or nursing women; having teeth darkened by
- •tetracycline, fluorosis or endodontic
- •treatment; patients with teeth grinding;
- •having noncarious
- •cervical lesion; and
- •dentin hypersensitivity.
研究者
相似试验
已完成
3 期
Evaluation of the effect of Nanohydroxyapatite on White Spot lesionsWhitespot lesion.IRCT20180928041162N1Shahid Beheshti University of Medical Sciences50
招募中
不适用
Open label trial for efficacy and safety of Hydroxychloroquine for systemic lupus erythematosusJPRN-UMIN000012478Department of Internal Medicine, Teikyo University School of Medicine10
已完成
3 期
Hyperbaric Oxygen for the Prevention of OsteoradioNecrosisISRCTN39634732niversity of Liverpool (UK)200
尚未招募
不适用
International study in multiple centers studying the effect of hydroxy-urea and temozolomide chemotherapy in patients with a recurrent malignant brain tumor (Glioblastoma)Brain tumor, glioma, glioblastoma, recurrent glioblastoma, glioblastoma multiformeHersentumor, glioom, glioblastoom, recidief glioblastoom, glioblastoma multiformeNL-OMON20720VU University Medical Center35
已完成
不适用
International Multicenter Phase I trial of Hydroxyurea in Combination with Dose-Intense Temozolomide in Recurrent Glioblastoma.High grade glioma10029211brain tumorNL-OMON50467Vrije Universiteit Medisch Centrum49